Request that the FDA grant permission to file an Abbreviated New Animal Drug Application (ANADA) for a generic oral soft-gel capsule for Nitenpyramthat differs from the pioneer product CAPSTAR (Nitenpyram) Tablets, sponsored by Sergeant’s Pet Care Products, LLC dba PetIQ under NADA 141-175. CAPSTAR is indicated to kill fleas and for treatment of flea infestations on dogs, puppies, cats and kitt | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-P-0056

Request that the FDA grant permission to file an Abbreviated New Animal Drug Application (ANADA) for a generic oral soft-gel capsule for Nitenpyramthat differs from the pioneer product CAPSTAR (Nitenpyram) Tablets, sponsored by Sergeant’s Pet Care Products, LLC dba PetIQ under NADA 141-175. CAPSTAR is indicated to kill fleas and for treatment of flea infestations on dogs, puppies, cats and kitt

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensJan 5, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Final Response Letter from FDA CVM to Regulatory Compliance Solutions LLC	Mar 11, 2026	--

Keywords

CVM

Suitability Petition

Flea Assassin, LLC

Regulatory Compliance Solutions LLC

grant permission to file an

Abbreviated New Animal Drug Application (ANADA)

for a generic oral soft-gel capsule for

Nitenpyramthat differs from the pioneer product

Data from Regulations.gov